Comprehensive Stock Analysis of Green Plains, Inc.(NASDAQ:GPRE): CorMedix Inc(NYSE:CRMD)

0
1

Green Plains, Inc. (GPRE) will report its next earnings on May 04 BMO. The company reported the earnings of $-0.6/Share in the last quarter where the estimated EPS by analysts was $-0.87/share. The difference between the expected and actual EPS was $0.27/share, which represents an Earnings surprise of 31%.

Many analysts are providing their Estimated Earnings analysis for Green Plains, Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.95/share. These analysts have also projected a Low Estimate of $-1.39/share and a High Estimate of $-0.77/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Green Plains, Inc. as 511.06 Million. According to these analysts, the Low Revenue Estimate for Green Plains, Inc. is 393.1 Million and the High Revenue Estimate is 650 Million. The company had Year Ago Sales of 811.23 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for GPRE to be 51.3%. They are projecting Next Quarter growth of 56.52%. For the next 5 years, Green Plains, Inc. is expecting Growth of 89.04% per annum, whereas in the past 5 years the growth was 52.02% per annum.

The Relative Volume of the company is 0.76 and Average Volume (3 months) is 744.49 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is -9.2%.

While looking at the Stock’s Performance, Green Plains, Inc. currently shows a Weekly Performance of 4.96%, where Monthly Performance is 14.24%, Quarterly performance is 148.67%, 6 Months performance is -33.44% and yearly performance percentage is -1.53%. Year to Date performance value (YTD perf) value is -33.44%. The Stock currently has a Weekly Volatility of 6.62% and Monthly Volatility of 7.70%.

CorMedix Inc (CRMD) will report its next earnings on May 11 AMC. The company reported the earnings of $-0.21/Share in the last quarter where the estimated EPS by analysts was $-0.23/share. The difference between the expected and actual EPS was $0.02/share, which represents an Earnings surprise of 8.7%.

Many analysts are providing their Estimated Earnings analysis for CorMedix Inc and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.14/share. These analysts have also projected a Low Estimate of $-0.24/share and a High Estimate of $-0.04/share.

In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for CorMedix Inc as 90 Million. According to these analysts, the Low Revenue Estimate for CorMedix Inc is 30 Million and the High Revenue Estimate is 150 Million. The company had Year Ago Sales of 130 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for CRMD to be 0%. They are projecting Next Quarter growth of -22.73%. For the next 5 years, CorMedix Inc is expecting Growth of 3.98% per annum, whereas in the past 5 years the growth was 1.12% per annum.

The Relative Volume of the company is 1.46 and Average Volume (3 months) is 211.71 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -148.7%. The Return on Equity (ROE) value stands at -194.3%. While it’s Return on Investment (ROI) value is -67.6%.

While looking at the Stock’s Performance, CorMedix Inc currently shows a Weekly Performance of 0.5%, where Monthly Performance is 30.47%, Quarterly performance is 92.41%, 6 Months performance is -16.48% and yearly performance percentage is -35.46%. Year to Date performance value (YTD perf) value is -16.48%. The Stock currently has a Weekly Volatility of 8.84% and Monthly Volatility of 9.98%.

SHARE